The latest report by IMARC Group, titled “Biosensors Market Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global biosensors market size reached US$ 28.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 55.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032.
Biosensors are analytical devices that combine biological components with transducers to detect, quantify, and analyze specific biological molecules or chemical substances. These devices are designed to provide real-time information about the presence and concentration of a particular biomolecule or analyte in a sample, often with high specificity and sensitivity. The biological component of a biosensor, known as the bioreceptor, can be an enzyme, antibody, DNA, or whole cell, depending on the target molecule. When the bioreceptor interacts with the target analyte, it generates a signal that is converted into a measurable output by the transducer. Common transducers include electrochemical, optical, and piezoelectric sensors. They offer rapid, specific, and often portable solutions for various fields, enabling quick and accurate analysis of biological and chemical substances in diverse samples. As a result, biosensors find extensive applications in healthcare, environmental monitoring, and the food industry across the globe, providing valuable insights into biological and chemical processes and aiding in disease diagnosis, quality control, and environmental protection.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/biosensors-market/requestsample
Biosensors Market Trends and Drivers:
The global biosensors market is primarily driven by the rising demand for biosensors across various medical applications due to the growing awareness of health and wellness, coupled with a heightened focus on early disease detection and monitoring. These devices offer rapid and accurate detection of biomarkers, making them crucial for point-of-care diagnostics. Apart from this, the rise of chronic diseases and the aging population have escalated the need for continuous monitoring and personalized healthcare solutions, thereby propelling market growth. Moreover, ongoing technological advancements in biosensor design, including miniaturization, improved sensitivity, and wireless connectivity, that expand their use in various fields, from healthcare to environmental monitoring and food safety, represent another major growth-inducing factor. Additionally, the widespread integration of biosensors into wearable health tech owing to the emerging trend toward wearable devices and the Internet of Things (IoT) that provides real-time health data to users is supporting market growth. Furthermore, the rising environmental impact of industrial processes and the need for rapid and accurate detection of pollutants has fueled the use of biosensors in environmental monitoring, thus contributing to market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Wearable Biosensors
- Non-Wearable Biosensors
Breakup by Technology:
- Electrochemical Biosensors
- Optical Biosensors
- Piezoelectric Biosensors
- Thermal Biosensors
- Nanomechanical Biosensors
- Others
Breakup by Application:
- Blood Glucose Testing
- Cholesterol Testing
- Blood Gas Analysis
- Pregnancy Testing
- Drug Discovery
- Infectious Disease Testing
- Others
Breakup by End Use:
- Point of Care Testing
- Home Healthcare Diagnostics
- Research Laboratories
- Security and Biodefense
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- AgaMatrix Inc. (WaveForm Technologies Inc)
- DuPont de Nemours Inc.
- F. Hoffmann-La Roche AG
- General Electric Company
- LifeScan Inc. (Platinum Equity LLC)
- Medtronic PLC
- Nova Biomedical Corporation
- PHC Holdings Corporation
- Siemens AG
- Thermo Fisher Scientific Inc.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
